MAIN COMPOUND PATENTS The active ingredient, semaglutide, as used in Novo Nordisks products Ozempic, Rybelsus and Wegovy is protected by two key compound patents, U.S
She can be reached at [email protected].
The catalytic site of the mitochondrial glycerol phosphate dehydrogenase is on the outer surface of the inner membrane, allowing ready access to the product of the second, or cytosolic, glycerol-3-phosphate dehydrogenase
It is produced by the body, recycled continuously and is found in fairly high concentrations in most human cells
Semaglutide can also improve blood sugar, blood pressure, heart health, and quality of life
Saxenda and Pancreatic Cancer In March 2013, the FDA issued a Safety Communication about a possible increased risk of pancreatitis and pre-cancerous cell changes in the pancreas of patients who were treated with Victoza (liraglutide), a diabetes medications that contains the same active ingredient as Saxenda